CLONIDINE

CLONIDINE was reported 51846 times

These side effects are most commonly reported by patients taking CLONIDINE:

# Side effect Count
0 DRUG INEFFECTIVE 4054
1 PAIN 3149
2 OFF LABEL USE 3086
3 NAUSEA 3078
4 FATIGUE 3070
5 HEADACHE 2979
6 HYPERTENSION 2740
7 DYSPNOEA 2388
8 DIARRHOEA 2365
9 VOMITING 2151
10 CHRONIC KIDNEY DISEASE 2117
11 DIZZINESS 1955
12 RENAL FAILURE 1922
13 ACUTE KIDNEY INJURY 1861
14 BLOOD PRESSURE INCREASED 1753
15 ANXIETY 1655
16 HYPOTENSION 1595
17 DEATH 1574
18 ASTHENIA 1482
19 BACK PAIN 1432
20 FALL 1411
21 CONSTIPATION 1384
22 PYREXIA 1380
23 RASH 1377
24 INSOMNIA 1344
25 COMPLETED SUICIDE 1333
26 MALAISE 1332
27 WEIGHT DECREASED 1307
28 PNEUMONIA 1283
29 HYPERHIDROSIS 1281
30 ARTHRALGIA 1202
31 SOMNOLENCE 1184
32 OVERDOSE 1181
33 PAIN IN EXTREMITY 1178
34 TOXICITY TO VARIOUS AGENTS 1170
35 END STAGE RENAL DISEASE 1124
36 WEIGHT INCREASED 1085
37 DEPRESSION 1057
38 PRODUCT USE ISSUE 1053
39 PRURITUS 1021
40 DECREASED APPETITE 1014
41 HYPERSENSITIVITY 1012
42 COUGH 1004
43 CONDITION AGGRAVATED 997
44 CHEST PAIN 985
45 FEELING ABNORMAL 971
46 ABDOMINAL PAIN 947
47 DRUG INTERACTION 923
48 DRUG HYPERSENSITIVITY 882
49 ERYTHEMA 860
50 TREMOR 860
51 INFUSION SITE PAIN 840
52 CEREBROVASCULAR ACCIDENT 833
53 URINARY TRACT INFECTION 811
54 OEDEMA PERIPHERAL 794
55 ASTHMA 775
56 CARDIAC FAILURE CONGESTIVE 773
57 GAIT DISTURBANCE 760
58 ANAEMIA 759
59 ABDOMINAL PAIN UPPER 757
60 DRUG WITHDRAWAL SYNDROME 745
61 FLUID RETENTION 738
62 BRADYCARDIA 736
63 HYPOAESTHESIA 735
64 CONFUSIONAL STATE 724
65 JOINT SWELLING 721
66 HEPATIC ENZYME INCREASED 713
67 MYOCARDIAL INFARCTION 708
68 MUSCLE SPASMS 705
69 RHEUMATOID ARTHRITIS 681
70 SEIZURE 679
71 INTENTIONAL PRODUCT MISUSE 675
72 UPPER RESPIRATORY TRACT INFECTION 669
73 DEHYDRATION 665
74 PERIPHERAL SWELLING 650
75 LOSS OF CONSCIOUSNESS 649
76 RENAL INJURY 643
77 PRODUCT DOSE OMISSION ISSUE 634
78 PRODUCT USE IN UNAPPROVED INDICATION 634
79 PRODUCT ADHESION ISSUE 628
80 INFECTION 613
81 CARDIAC ARREST 612
82 PRODUCT QUALITY ISSUE 586
83 BLOOD GLUCOSE INCREASED 583
84 AGITATION 581
85 ABDOMINAL DISCOMFORT 577
86 RASH ERYTHEMATOUS 575
87 IMMUNODEFICIENCY 573
88 NEPHROGENIC ANAEMIA 564
89 VISION BLURRED 561
90 THROMBOCYTOPENIA 560
91 AGGRESSION 557
92 INFUSION RELATED REACTION 554
93 MUSCULAR WEAKNESS 553
94 EXPOSURE DURING PREGNANCY 551
95 FOOD ALLERGY 548
96 HEART RATE INCREASED 536
97 MYALGIA 531
98 INFUSION SITE ERYTHEMA 524
99 EMOTIONAL DISTRESS 523
100 DRUG INTOLERANCE 521
101 PARAESTHESIA 520
102 TACHYCARDIA 519
103 ALOPECIA 518
104 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 506
105 SEPSIS 505
106 DRY MOUTH 502
107 GASTROOESOPHAGEAL REFLUX DISEASE 501
108 PRESCRIBED OVERDOSE 497
109 DRUG DOSE OMISSION 495
110 PALPITATIONS 486
111 SYNCOPE 483
112 NASOPHARYNGITIS 469
113 DRUG DEPENDENCE 465
114 CONTUSION 460
115 MEMORY IMPAIRMENT 460
116 CHILLS 459
117 SUICIDAL IDEATION 456
118 TREATMENT FAILURE 456
119 LETHARGY 455
120 RESPIRATORY FAILURE 450
121 URTICARIA 444
122 ATRIAL FIBRILLATION 441
123 PSORIASIS 439
124 RENAL IMPAIRMENT 438
125 BLOOD CREATININE INCREASED 432
126 HAEMOGLOBIN DECREASED 432
127 TEMPERATURE REGULATION DISORDER 430
128 WITHDRAWAL SYNDROME 428
129 BURSITIS 427
130 BLOOD PRESSURE DECREASED 426
131 MENTAL STATUS CHANGES 423
132 GASTROINTESTINAL HAEMORRHAGE 422
133 DYSPEPSIA 418
134 APPLICATION SITE PRURITUS 416
135 INJECTION SITE PAIN 414
136 COELIAC DISEASE 408
137 DYSPHAGIA 408
138 INJURY 407
139 HALLUCINATION 404
140 INCORRECT DOSE ADMINISTERED 402
141 ABDOMINAL DISTENSION 401
142 MIGRAINE 397
143 DIABETES MELLITUS 390
144 DRUG ABUSE 387
145 APPLICATION SITE ERYTHEMA 386
146 CARDIO-RESPIRATORY ARREST 384
147 SINUSITIS 377
148 CONTRAINDICATED PRODUCT ADMINISTERED 374
149 GENERAL PHYSICAL HEALTH DETERIORATION 374
150 INFUSION SITE SWELLING 374
151 SEDATION 368
152 NEUROPATHY PERIPHERAL 364
153 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 353
154 IRRITABILITY 350
155 SWELLING 350
156 CHEST DISCOMFORT 349
157 HOSPITALISATION 347
158 RENAL FAILURE ACUTE 347
159 FLUSHING 346
160 INFLUENZA 343
161 INTENTIONAL OVERDOSE 340
162 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 330
163 SLEEP DISORDER 329
164 BALANCE DISORDER 328
165 OEDEMA 324
166 THERAPY NON-RESPONDER 321
167 OXYGEN SATURATION DECREASED 320
168 CELLULITIS 312
169 CARDIAC DISORDER 311
170 VISUAL IMPAIRMENT 310
171 STRESS 307
172 CONVULSION 306
173 UNEVALUABLE EVENT 305
174 TREATMENT NONCOMPLIANCE 304
175 BRONCHITIS 302
176 ABNORMAL BEHAVIOUR 301
177 DEVICE ISSUE 300
178 EPISTAXIS 300
179 COVID-19 298
180 HYPERPARATHYROIDISM SECONDARY 296
181 ILLNESS 295
182 BURNING SENSATION 293
183 MOBILITY DECREASED 292
184 PULMONARY OEDEMA 292
185 OBESITY 291
186 DYSKINESIA 290
187 PLATELET COUNT DECREASED 289
188 RENAL DISORDER 289
189 PRODUCT SUBSTITUTION ISSUE 288
190 TYPE 2 DIABETES MELLITUS 285
191 OROPHARYNGEAL PAIN 284
192 DISTURBANCE IN ATTENTION 283
193 HYPERKALAEMIA 283
194 CORONARY ARTERY DISEASE 281
195 HYPOKALAEMIA 280
196 ANHEDONIA 276
197 NECK PAIN 274
198 SPEECH DISORDER 274
199 MUSCULOSKELETAL STIFFNESS 273
200 RESPIRATORY DEPRESSION 273
201 HEART RATE DECREASED 272
202 HYPOGLYCAEMIA 269
203 AMNESIA 267
204 HYPONATRAEMIA 264
205 SUICIDE ATTEMPT 262
206 FOETAL DEATH 259
207 NO ADVERSE EVENT 256
208 STOMATITIS 256
209 RESPIRATORY ARREST 255
210 DEPRESSED LEVEL OF CONSCIOUSNESS 254
211 BLOOD PRESSURE FLUCTUATION 253
212 HYPERTENSIVE CRISIS 253
213 DELIRIUM 251
214 PLEURAL EFFUSION 251
215 MEDICATION ERROR 250
216 HAEMORRHAGE 248
217 CARDIAC FAILURE 245
218 INTENTIONAL PRODUCT USE ISSUE 244
219 NERVOUSNESS 243
220 UNRESPONSIVE TO STIMULI 243
221 PANCREATITIS 242
222 RHABDOMYOLYSIS 241
223 INFUSION SITE HAEMORRHAGE 240
224 ADVERSE DRUG REACTION 239
225 THROMBOSIS 239
226 PSYCHOMOTOR HYPERACTIVITY 237
227 PULMONARY EMBOLISM 237
228 WHEEZING 237
229 MUSCULOSKELETAL PAIN 236
230 HYPOXIA 235
231 THERAPEUTIC RESPONSE DECREASED 235
232 BLISTER 232
233 CATARACT 232
234 RESTLESSNESS 232
235 TUBULOINTERSTITIAL NEPHRITIS 231
236 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 229
237 ELECTROCARDIOGRAM QT PROLONGED 229
238 FEELING HOT 229
239 BLOOD CHOLESTEROL INCREASED 228
240 DRUG EFFECT DECREASED 228
241 HOT FLUSH 228
242 DEVICE MALFUNCTION 227
243 BONE PAIN 226
244 OSTEOARTHRITIS 225
245 SWELLING FACE 224
246 ACUTE MYOCARDIAL INFARCTION 220
247 GASTROINTESTINAL DISORDER 219
248 COMA 218
249 TRANSIENT ISCHAEMIC ATTACK 218
250 DYSGEUSIA 215
251 WHITE BLOOD CELL COUNT DECREASED 215
252 POOR QUALITY SLEEP 213
253 ANGER 210
254 APPLICATION SITE RASH 210
255 UNDERDOSE 210
256 CRYING 209
257 DEVICE DISLOCATION 208
258 ARTHRITIS 207
259 ADVERSE EVENT 206
260 SINUS BRADYCARDIA 205
261 HYPERGLYCAEMIA 203
262 NEUTROPENIA 203
263 NASAL CONGESTION 201
264 SKIN DISCOLOURATION 201
265 INFLUENZA LIKE ILLNESS 200
266 ACCIDENTAL OVERDOSE 199
267 DISORIENTATION 199
268 DRY SKIN 199
269 DEVICE FAILURE 198
270 ROAD TRAFFIC ACCIDENT 197
271 DEEP VEIN THROMBOSIS 196
272 DYSARTHRIA 196
273 RHINORRHOEA 195
274 SLEEP APNOEA SYNDROME 195
275 URINARY INCONTINENCE 195
276 DYSPHONIA 194
277 ECONOMIC PROBLEM 193
278 BLOOD GLUCOSE DECREASED 188
279 HERPES ZOSTER 188
280 DISEASE PROGRESSION 187
281 BLOOD PRESSURE INADEQUATELY CONTROLLED 185
282 DYSPNOEA EXERTIONAL 185
283 DEPRESSED MOOD 184
284 DEVICE INFUSION ISSUE 184
285 HAEMATURIA 184
286 ARRHYTHMIA 182
287 HYPERSOMNIA 182
288 WRONG TECHNIQUE IN DRUG USAGE PROCESS 182
289 TINNITUS 181
290 MENTAL DISORDER 180
291 DYSURIA 178
292 STAPHYLOCOCCAL INFECTION 178
293 SUSPECTED SUICIDE 178
294 RETCHING 177
295 HYPERLIPIDAEMIA 176
296 RESPIRATORY DISTRESS 176
297 FEAR 175
298 HYPOPHAGIA 175
299 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 175
300 PANIC ATTACK 175
301 BLOOD PRESSURE ABNORMAL 174
302 FIBROMYALGIA 174
303 REBOUND ACID HYPERSECRETION 174
304 DYSTONIA 173
305 RECTAL HAEMORRHAGE 170
306 VERTIGO 169
307 BLOOD POTASSIUM DECREASED 168
308 CYSTITIS 168
309 FLATULENCE 168
310 TARDIVE DYSKINESIA 165
311 BLOOD PRESSURE SYSTOLIC INCREASED 164
312 EXTRAPYRAMIDAL DISORDER 164
313 SKIN DISORDER 164
314 HAEMATOCHEZIA 163
315 MOOD SWINGS 163
316 SKIN EXFOLIATION 163
317 POLLAKIURIA 162
318 ANAPHYLACTIC REACTION 161
319 INFUSION SITE INFECTION 161
320 OSTEOPOROSIS 161
321 PRODUCT DOSE OMISSION 161
322 APPLICATION SITE PAIN 160
323 DEVICE OCCLUSION 160
324 DISCOMFORT 160
325 LUNG DISORDER 160
326 DERMATITIS CONTACT 159
327 MATERNAL EXPOSURE DURING PREGNANCY 159
328 EMOTIONAL DISORDER 158
329 GYNAECOMASTIA 158
330 RENAL TUBULAR NECROSIS 157
331 PAIN IN JAW 156
332 SEROTONIN SYNDROME 156
333 NEPHROPATHY 155
334 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 155
335 METABOLIC ACIDOSIS 154
336 INFUSION SITE DISCHARGE 153
337 PRODUCT PRESCRIBING ERROR 153
338 VIRAL INFECTION 153
339 IMPAIRED HEALING 152
340 ALANINE AMINOTRANSFERASE INCREASED 151
341 DEVICE LEAKAGE 151
342 GASTRITIS 150
343 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 150
344 HYPOTHYROIDISM 149
345 INFLAMMATION 149
346 TOXIC EPIDERMAL NECROLYSIS 149
347 ASPARTATE AMINOTRANSFERASE INCREASED 147
348 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 147
349 SEPTIC SHOCK 147
350 WHITE BLOOD CELL COUNT INCREASED 146
351 LEUKOPENIA 145
352 FEBRILE NEUTROPENIA 144
353 INJECTION SITE REACTION 144
354 RENAL FAILURE CHRONIC 144
355 FOETAL EXPOSURE DURING PREGNANCY 143
356 JOINT STIFFNESS 143
357 POISONING 142
358 URINARY RETENTION 141
359 APPLICATION SITE IRRITATION 140
360 PULMONARY HYPERTENSION 140
361 DRUG ADMINISTRATION ERROR 138
362 NIGHTMARE 138
363 THERAPY INTERRUPTED 137
364 ACUTE RESPIRATORY FAILURE 136
365 NEPHROGENIC SYSTEMIC FIBROSIS 135
366 PANCYTOPENIA 135
367 APHASIA 134
368 CROHN^S DISEASE 134
369 IMPAIRED QUALITY OF LIFE 134
370 INJECTION SITE ERYTHEMA 134
371 LYMPHADENOPATHY 134
372 PRESYNCOPE 134
373 EYE PAIN 133
374 ILL-DEFINED DISORDER 133
375 NEPHROLITHIASIS 133
376 SWOLLEN TONGUE 133
377 BONE DENSITY DECREASED 132
378 MOVEMENT DISORDER 132
379 NEUROLEPTIC MALIGNANT SYNDROME 132
380 HEAD INJURY 131
381 SURGERY 131
382 THERAPEUTIC RESPONSE UNEXPECTED 131
383 IMPAIRED GASTRIC EMPTYING 130
384 INFUSION SITE REACTION 130
385 THERAPY CESSATION 130
386 CARDIOMEGALY 129
387 ANGINA PECTORIS 128
388 BLOOD SODIUM DECREASED 128
389 JOINT RANGE OF MOTION DECREASED 128
390 RASH PRURITIC 128
391 MOOD ALTERED 127
392 THROAT IRRITATION 127
393 ARTHROPATHY 126
394 BLOOD POTASSIUM INCREASED 126
395 CHOLELITHIASIS 126
396 GOUT 126
397 PSYCHOTIC DISORDER 126
398 BLOOD UREA INCREASED 124
399 PERICARDIAL EFFUSION 124
400 DYSSTASIA 123
401 GAIT INABILITY 123
402 INFUSION SITE PRURITUS 123
403 EAR INFECTION 122
404 ANGIOEDEMA 121
405 IMPAIRED WORK ABILITY 121
406 RESPIRATORY DISORDER 121
407 HAEMORRHOIDS 120
408 ENCEPHALOPATHY 119
409 FLUID OVERLOAD 119
410 INTERNATIONAL NORMALISED RATIO INCREASED 119
411 PRODUCTIVE COUGH 119
412 COGNITIVE DISORDER 118
413 BLOOD TRIGLYCERIDES INCREASED 117
414 FEELING COLD 117
415 INFUSION SITE INDURATION 117
416 HAEMATOCRIT DECREASED 116
417 HAEMATOMA 116
418 NEURALGIA 116
419 HYPERAESTHESIA 115
420 MUCOSAL INFLAMMATION 115
421 PNEUMONIA ASPIRATION 115
422 BLINDNESS 114
423 INTESTINAL OBSTRUCTION 114
424 MULTI-ORGAN FAILURE 114
425 MUSCLE TWITCHING 114
426 SKIN BURNING SENSATION 114
427 STEVENS-JOHNSON SYNDROME 114
428 DRY EYE 113
429 LEFT VENTRICULAR HYPERTROPHY 113
430 LIMB INJURY 113
431 SKIN LESION 113
432 LACTIC ACIDOSIS 112
433 LIP SWELLING 112
434 MALIGNANT NEOPLASM PROGRESSION 112
435 NIGHT SWEATS 112
436 WOUND 112
437 ABASIA 110
438 HALLUCINATION, VISUAL 110
439 IRRITABLE BOWEL SYNDROME 110
440 LEUKOCYTOSIS 110
441 INJECTION SITE BRUISING 109
442 PARADOXICAL DRUG REACTION 109
443 PULMONARY CONGESTION 109
444 PALLOR 108
445 PROTEINURIA 108
446 CEREBRAL HAEMORRHAGE 107
447 HYPOACUSIS 107
448 INFUSION SITE IRRITATION 107
449 NO THERAPEUTIC RESPONSE 107
450 ORAL PAIN 107
451 PANCREATITIS ACUTE 107
452 SKIN ULCER 107
453 CARDIOMYOPATHY 106
454 DIALYSIS 106
455 GASTROENTERITIS VIRAL 106
456 HEPATIC STEATOSIS 106
457 EYE DISORDER 105
458 LOWER RESPIRATORY TRACT INFECTION 105
459 MIOSIS 105
460 AKATHISIA 104
461 BODY TEMPERATURE INCREASED 104
462 DEVICE USE ERROR 104
463 HAEMATEMESIS 104
464 HAEMOPTYSIS 104
465 HEART RATE IRREGULAR 104
466 MANIA 104
467 MUSCLE SPASTICITY 104
468 COAGULOPATHY 103
469 DIABETES MELLITUS INADEQUATE CONTROL 103
470 HALLUCINATION, AUDITORY 103
471 MIDDLE INSOMNIA 103
472 ANURIA 102
473 KIDNEY INFECTION 102
474 RED BLOOD CELL COUNT DECREASED 102
475 TENDERNESS 102
476 DIVERTICULITIS 101
477 GENERALISED TONIC-CLONIC SEIZURE 101
478 HYPERCHOLESTEROLAEMIA 101
479 DEVICE MAINTENANCE ISSUE 100
480 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 100
481 EYE IRRITATION 100
482 LOCALISED INFECTION 100
483 PARANOIA 100
484 ASCITES 99
485 EYE SWELLING 99
486 VISUAL ACUITY REDUCED 99
487 DEVICE DIFFICULT TO USE 98
488 INTERVERTEBRAL DISC PROTRUSION 98
489 OSTEOMYELITIS 98
490 BLOOD CREATINE PHOSPHOKINASE INCREASED 97
491 ACCIDENTAL EXPOSURE TO PRODUCT 96
492 DRUG EFFECT INCOMPLETE 96
493 HIP FRACTURE 96
494 INJECTION SITE HAEMORRHAGE 96
495 LIMB DISCOMFORT 96
496 APLASTIC ANAEMIA 95
497 KIDNEY TRANSPLANT REJECTION 95
498 MENTAL IMPAIRMENT 95
499 RESTLESS LEGS SYNDROME 95
500 ARTERIOSCLEROSIS 94
501 HYPOTONIA 94
502 INCREASED APPETITE 94
503 INJECTION SITE MASS 94
504 INTENTIONAL DRUG MISUSE 93
505 JOINT DISLOCATION 93
506 NERVOUS SYSTEM DISORDER 93
507 ORTHOSTATIC HYPOTENSION 93
508 TIC 93
509 ACTIVITIES OF DAILY LIVING IMPAIRED 92
510 COLD SWEAT 92
511 COLITIS 92
512 HIATUS HERNIA 92
513 HYPOTHERMIA 92
514 MYOCLONUS 92
515 SUPRAVENTRICULAR TACHYCARDIA 92
516 DRUG TOXICITY 91
517 EAR PAIN 91
518 FEEDING DISORDER 91
519 GASTRIC DISORDER 91
520 DIPLOPIA 90
521 DRUG LEVEL INCREASED 90
522 EATING DISORDER 90
523 BRAIN INJURY 89
524 BREAST CANCER 89
525 SCAR 89
526 DEVICE POWER SOURCE ISSUE 88
527 DRUG PRESCRIBING ERROR 88
528 GLUCOSE TOLERANCE IMPAIRED 88
529 ORAL HERPES 88
530 SCIATICA 88
531 THROAT TIGHTNESS 88
532 DIABETIC KETOACIDOSIS 87
533 INFUSION SITE WARMTH 87
534 LIVER INJURY 87
535 PERITONITIS 87
536 PRODUCT AVAILABILITY ISSUE 87
537 ABNORMAL DREAMS 86
538 CARDIOGENIC SHOCK 86
539 GALLBLADDER DISORDER 86
540 TOOTH LOSS 86
541 CANDIDA INFECTION 85
542 POST PROCEDURAL COMPLICATION 85
543 SEASONAL ALLERGY 85
544 SKIN IRRITATION 85
545 APPLICATION SITE VESICLES 84
546 BLOOD ALKALINE PHOSPHATASE INCREASED 84
547 LABORATORY TEST ABNORMAL 84
548 PERITONITIS BACTERIAL 84
549 PURULENT DISCHARGE 84
550 RASH MACULAR 84
551 RENAL CYST 84
552 SHOCK 84
553 THERAPEUTIC PRODUCT EFFECT DECREASED 84
554 BONE DISORDER 83
555 DEVICE RELATED INFECTION 83
556 FULL BLOOD COUNT DECREASED 83
557 HOMICIDAL IDEATION 83
558 PRODUCT PACKAGING QUANTITY ISSUE 83
559 THERAPY PARTIAL RESPONDER 83
560 APNOEA 82
561 BACK DISORDER 82
562 BLOOD URINE PRESENT 82
563 FUNGAL INFECTION 82
564 INTENTIONAL SELF-INJURY 82
565 JOINT INJURY 82
566 LIVER DISORDER 82
567 MUSCLE TIGHTNESS 82
568 PHARMACEUTICAL PRODUCT COMPLAINT 82
569 ACUTE RESPIRATORY DISTRESS SYNDROME 81
570 CARDIOVASCULAR DISORDER 81
571 DRUG SCREEN POSITIVE 81
572 FOOT FRACTURE 81
573 INCORRECT DRUG ADMINISTRATION DURATION 81
574 INJECTION SITE PRURITUS 81
575 LOWER LIMB FRACTURE 81
576 NEOPLASM MALIGNANT 81
577 PRODUCT PRESCRIBING ISSUE 81
578 ASPIRATION 80
579 CHROMATURIA 80
580 INJECTION SITE SWELLING 80
581 OSTEOPENIA 80
582 ATELECTASIS 79
583 C-REACTIVE PROTEIN INCREASED 79
584 COORDINATION ABNORMAL 79
585 MULTIPLE ORGAN DYSFUNCTION SYNDROME 79
586 BACTERIAL INFECTION 78
587 BIPOLAR DISORDER 78
588 DEMENTIA 78
589 FEELING JITTERY 78
590 HEMIPARESIS 78
591 SINUS DISORDER 78
592 GLYCOSYLATED HAEMOGLOBIN INCREASED 77
593 MOUTH ULCERATION 77
594 APPLICATION SITE BURN 76
595 CATATONIA 76
596 HYPOKINESIA 76
597 INTERVERTEBRAL DISC DEGENERATION 76
598 MYDRIASIS 76
599 OCULAR HYPERAEMIA 76
600 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 76
601 SPINAL OSTEOARTHRITIS 76
602 THIRST 76
603 UPPER LIMB FRACTURE 76
604 DEVICE BREAKAGE 75
605 HAEMORRHAGE INTRACRANIAL 75
606 MYOCARDIAL ISCHAEMIA 75
607 SINUS TACHYCARDIA 75
608 ANKLE FRACTURE 74
609 DECREASED ACTIVITY 74
610 DECREASED IMMUNE RESPONSIVENESS 74
611 ILEUS 74
612 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 74
613 INTENTIONAL DOSE OMISSION 74
614 PHARYNGEAL OEDEMA 74
615 THINKING ABNORMAL 74
616 ACNE 73
617 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 73
618 CHOLECYSTITIS 73
619 CORONARY ARTERY OCCLUSION 73
620 MITRAL VALVE INCOMPETENCE 73
621 MUSCULOSKELETAL CHEST PAIN 73
622 RASH GENERALISED 73
623 DISEASE RECURRENCE 72
624 HEPATIC FAILURE 72
625 INFUSION SITE NODULE 72
626 LOCAL SWELLING 72
627 MALNUTRITION 72
628 NEUROTOXICITY 72
629 PURPURA 72
630 RIB FRACTURE 72
631 SYSTEMIC LUPUS ERYTHEMATOSUS 72
632 ELECTROLYTE IMBALANCE 71
633 PULMONARY MASS 71
634 TOOTHACHE 71
635 VENTRICULAR TACHYCARDIA 71
636 EJECTION FRACTION DECREASED 70
637 GLOSSODYNIA 70
638 LACRIMATION INCREASED 70
639 MUSCULOSKELETAL DISCOMFORT 70
640 SENSORY DISTURBANCE 70
641 URINE OUTPUT DECREASED 70
642 VAGINAL HAEMORRHAGE 70
643 EXPIRED PRODUCT ADMINISTERED 69
644 GLOMERULAR FILTRATION RATE DECREASED 69
645 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 69
646 ALTERED STATE OF CONSCIOUSNESS 68
647 BLOOD PROLACTIN INCREASED 68
648 DENTAL CARIES 68
649 DIABETIC NEUROPATHY 68
650 HERNIA 68
651 LIVER FUNCTION TEST ABNORMAL 68
652 MULTIPLE SCLEROSIS RELAPSE 68
653 OVERWEIGHT 68
654 AFFECTIVE DISORDER 67
655 CLOSTRIDIUM DIFFICILE INFECTION 67
656 DEVICE WIRELESS COMMUNICATION ISSUE 67
657 GENERALISED OEDEMA 67
658 MULTIPLE DRUG OVERDOSE 67
659 PREMATURE BABY 67
660 PRODUCT ADMINISTRATION ERROR 67
661 PRODUCT PHYSICAL ISSUE 67
662 SPINAL PAIN 67
663 UPPER GASTROINTESTINAL HAEMORRHAGE 67
664 INFUSION SITE MASS 66
665 MULTIPLE SCLEROSIS 66
666 PROCTALGIA 66
667 PULMONARY ARTERIAL HYPERTENSION 66
668 QUALITY OF LIFE DECREASED 66
669 CARDIAC MURMUR 65
670 DERMATITIS 65
671 DROOLING 65
672 GASTROENTERITIS 65
673 HAEMODIALYSIS 65
674 HIP ARTHROPLASTY 65
675 LUNG NEOPLASM MALIGNANT 65
676 AFFECT LABILITY 64
677 HAIR COLOUR CHANGES 64
678 KNEE ARTHROPLASTY 64
679 LUNG INFILTRATION 64
680 MASS 64
681 POST-TRAUMATIC STRESS DISORDER 64
682 PROCEDURAL PAIN 64
683 SKIN INDURATION 64
684 TACHYPNOEA 64
685 TRICUSPID VALVE INCOMPETENCE 64
686 DEVICE ALARM ISSUE 63
687 DISABILITY 63
688 DIZZINESS POSTURAL 63
689 DRUG DOSE OMISSION BY DEVICE 63
690 EYE HAEMORRHAGE 63
691 INCONTINENCE 63
692 NODULE 63
693 PRODUCT PREPARATION ERROR 63
694 SKIN HYPERTROPHY 63
695 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 62
696 BLOOD BILIRUBIN INCREASED 62
697 BLOOD GLUCOSE ABNORMAL 62
698 CYANOSIS 62
699 DELUSION 62
700 HAIR TEXTURE ABNORMAL 62
701 PRURITUS GENERALISED 62
702 RESPIRATORY TRACT INFECTION 62
703 TOOTH DISORDER 62
704 WOUND INFECTION 62
705 BLOOD MAGNESIUM DECREASED 61
706 CHOKING 61
707 DRUG TOLERANCE 61
708 ECZEMA 61
709 ELECTROCARDIOGRAM ABNORMAL 61
710 HYPERVOLAEMIA 61
711 ORAL CANDIDIASIS 61
712 PRODUCT ADMINISTRATION INTERRUPTED 61
713 RED BLOOD CELL SEDIMENTATION RATE INCREASED 61
714 ATRIOVENTRICULAR BLOCK FIRST DEGREE 60
715 DISSOCIATION 60
716 DIVERTICULUM 60
717 DRUG-INDUCED LIVER INJURY 60
718 EXTRA DOSE ADMINISTERED 60
719 NEOVASCULARISATION 60
720 SNEEZING 60
721 SPLENOMEGALY 60
722 CONJUNCTIVITIS 59
723 FAECES DISCOLOURED 59
724 FREQUENT BOWEL MOVEMENTS 59
725 HYPOMAGNESAEMIA 59
726 INADEQUATE ANALGESIA 59
727 INFECTION SUSCEPTIBILITY INCREASED 59
728 INHIBITORY DRUG INTERACTION 59
729 NEUTROPHIL COUNT DECREASED 59
730 ROTATOR CUFF SYNDROME 59
731 SPINAL FRACTURE 59
732 ACIDOSIS 58
733 ANOREXIA 58
734 BRUXISM 58
735 DEAFNESS 58
736 ERECTILE DYSFUNCTION 58
737 IMPAIRED DRIVING ABILITY 58
738 IMPLANT SITE PAIN 58
739 INFUSION SITE DISCOLOURATION 58
740 KLEBSIELLA INFECTION 58
741 LYMPHOEDEMA 58
742 OBSESSIVE-COMPULSIVE DISORDER 58
743 ULCER 58
744 RASH PAPULAR 57
745 RESPIRATORY TRACT CONGESTION 57
746 AUTOIMMUNE DISORDER 56
747 BACTERAEMIA 56
748 BODY HEIGHT DECREASED 56
749 HYPOVOLAEMIA 56
750 INFUSION SITE BRUISING 56
751 JUVENILE IDIOPATHIC ARTHRITIS 56
752 PAIN OF SKIN 56
753 PHOTOPHOBIA 56
754 PSORIATIC ARTHROPATHY 56
755 TRISMUS 56
756 BODY TINEA 55
757 BRAIN FOG 55
758 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 55
759 GLAUCOMA 55
760 OBSTRUCTIVE AIRWAYS DISORDER 55
761 PARALYSIS 55
762 PERIPHERAL COLDNESS 55
763 PRESCRIBED UNDERDOSE 55
764 SKIN TIGHTNESS 55
765 SPRUE-LIKE ENTEROPATHY 55
766 AGEUSIA 54
767 ARTERIOSCLEROSIS CORONARY ARTERY 54
768 CARPAL TUNNEL SYNDROME 54
769 CEREBRAL INFARCTION 54
770 EPIDURAL LIPOMATOSIS 54
771 INCORRECT ROUTE OF DRUG ADMINISTRATION 54
772 LIVER FUNCTION TEST INCREASED 54
773 PRODUCT STORAGE ERROR 54
774 PSYCHOLOGICAL TRAUMA 54
775 SCREAMING 54
776 SMALL INTESTINAL OBSTRUCTION 54
777 THERAPEUTIC RESPONSE SHORTENED 54
778 TOOTH INFECTION 54
779 VENTRICULAR FIBRILLATION 54
780 ABDOMINAL PAIN LOWER 53
781 ATAXIA 53
782 BLINDNESS UNILATERAL 53
783 BLOOD IRON DECREASED 53
784 DERMATITIS ATOPIC 53
785 FEMUR FRACTURE 53
786 GINGIVAL BLEEDING 53
787 HEPATIC CIRRHOSIS 53
788 HYPERVENTILATION 53
789 HYPOCALCAEMIA 53
790 HYPOVENTILATION 53
791 MUSCLE RIGIDITY 53
792 NEEDLE ISSUE 53
793 POLYURIA 53
794 VASCULITIS 53
795 WITHDRAWAL HYPERTENSION 53
796 BEHAVIOUR DISORDER 52
797 BLOOD COUNT ABNORMAL 52
798 EYE PRURITUS 52
799 FIBROSIS 52
800 INITIAL INSOMNIA 52
801 JAUNDICE 52
802 NEUROLOGICAL SYMPTOM 52
803 PLASMA CELL MYELOMA 52
804 SALIVARY HYPERSECRETION 52
805 SUBSTANCE ABUSE 52
806 TRANSFUSION 52
807 VENTRICULAR EXTRASYSTOLES 52
808 VITAMIN D DEFICIENCY 52
809 BLOOD CALCIUM DECREASED 51
810 COMPLICATION ASSOCIATED WITH DEVICE 51
811 DEVICE PHYSICAL PROPERTY ISSUE 51
812 DRUG DISPENSING ERROR 51
813 FLANK PAIN 51
814 INTERVERTEBRAL DISC DISORDER 51
815 LYMPHOCYTE COUNT DECREASED 51
816 THYROID DISORDER 51
817 TOOTH ABSCESS 51
818 TOOTH FRACTURE 51
819 ABDOMINAL TENDERNESS 50
820 ACCIDENT 50
821 ACUTE CORONARY SYNDROME 50
822 ANAL INCONTINENCE 50
823 BACK INJURY 50
824 BUNDLE BRANCH BLOCK LEFT 50
825 GASTRIC ULCER 50
826 HYPERTENSIVE EMERGENCY 50
827 MEDICAL DEVICE COMPLICATION 50
828 NERVE INJURY 50
829 PHOTOSENSITIVITY REACTION 50
830 RALES 50
831 RESPIRATORY RATE INCREASED 50
832 TYPE 1 DIABETES MELLITUS 50
833 BRONCHOSPASM 49
834 DEVICE CONNECTION ISSUE 49
835 DISTRIBUTIVE SHOCK 49
836 GRAND MAL CONVULSION 49
837 HAEMOGLOBIN INCREASED 49
838 HELICOBACTER INFECTION 49
839 HYPERREFLEXIA 49
840 HYPERTHERMIA 49
841 HYPOAESTHESIA ORAL 49
842 IMPLANT SITE EXTRAVASATION 49
843 IRON DEFICIENCY ANAEMIA 49
844 ISCHAEMIC STROKE 49
845 LOWER GASTROINTESTINAL HAEMORRHAGE 49
846 MADAROSIS 49
847 RENAL TRANSPLANT 49
848 SCOLIOSIS 49
849 SUBARACHNOID HAEMORRHAGE 49
850 VICTIM OF CHILD ABUSE 49
851 ANAPHYLACTIC SHOCK 48
852 ATRIAL FLUTTER 48
853 ATRIOVENTRICULAR BLOCK 48
854 BODY TEMPERATURE DECREASED 48
855 BRAIN OEDEMA 48
856 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 48
857 HAIR DISORDER 48
858 INFUSION SITE INFLAMMATION 48
859 MULTIPLE FRACTURES 48
860 MULTIPLE INJURIES 48
861 ORAL DISCOMFORT 48
862 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 48
863 PNEUMONITIS 48
864 PULSELESS ELECTRICAL ACTIVITY 48
865 TASTE DISORDER 48
866 BLOOD PRESSURE DIASTOLIC DECREASED 47
867 DECUBITUS ULCER 47
868 EPILEPSY 47
869 HYPERCALCAEMIA 47
870 IMPULSIVE BEHAVIOUR 47
871 SKIN ATROPHY 47
872 SKIN CANCER 47
873 TRANSPLANT REJECTION 47
874 UNINTENTIONAL MEDICAL DEVICE REMOVAL 47
875 ERUCTATION 46
876 FEELING OF BODY TEMPERATURE CHANGE 46
877 HUNGER 46
878 MUSCLE ATROPHY 46
879 PERIPHERAL VASCULAR DISORDER 46
880 PRODUCT DOSE OMISSION IN ERROR 46
881 ALCOHOLISM 45
882 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 45
883 BLOOD GLUCOSE FLUCTUATION 45
884 DRUG LEVEL DECREASED 45
885 HEAD DISCOMFORT 45
886 HEPATOMEGALY 45
887 INCREASED TENDENCY TO BRUISE 45
888 INFUSION SITE DISCOMFORT 45
889 INFUSION SITE RASH 45
890 LACERATION 45
891 MAJOR DEPRESSION 45
892 MUSCULOSKELETAL DISORDER 45
893 NOCTURIA 45
894 PARKINSON^S DISEASE 45
895 PLATELET COUNT INCREASED 45
896 PNEUMOTHORAX 45
897 SKIN LACERATION 45
898 SPINAL DISORDER 45
899 TEMPERATURE INTOLERANCE 45
900 TORSADE DE POINTES 45
901 BLOOD ALBUMIN DECREASED 44
902 DEVICE ADHESION ISSUE 44
903 DRUG ADMINISTERED AT INAPPROPRIATE SITE 44
904 OESOPHAGEAL PAIN 44
905 OESOPHAGITIS 44
906 REFUSAL OF TREATMENT BY PATIENT 44
907 CLOSTRIDIUM DIFFICILE COLITIS 43
908 DEFORMITY 43
909 DEVICE KINK 43
910 DIABETIC RETINOPATHY 43
911 DRUG WITHDRAWAL SYNDROME NEONATAL 43
912 ECCHYMOSIS 43
913 HAEMODYNAMIC INSTABILITY 43
914 HYDRONEPHROSIS 43
915 MONOPLEGIA 43
916 OPPOSITIONAL DEFIANT DISORDER 43
917 SCAB 43
918 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 43
919 STREPTOCOCCAL INFECTION 43
920 VITAMIN D DECREASED 43
921 ANGINA UNSTABLE 42
922 AUTONOMIC NERVOUS SYSTEM IMBALANCE 42
923 CHILD ABUSE 42
924 COLITIS ULCERATIVE 42
925 DRUG ABUSER 42
926 HEPATOTOXICITY 42
927 HYPOALBUMINAEMIA 42
928 INCOHERENT 42
929 INGUINAL HERNIA 42
930 INSURANCE ISSUE 42
931 PETECHIAE 42
932 PRODUCT USE COMPLAINT 42
933 REBOUND EFFECT 42
934 SEDATION COMPLICATION 42
935 SENSORY LOSS 42
936 SINUS CONGESTION 42
937 SOMNAMBULISM 42
938 SUBDURAL HAEMATOMA 42
939 APPLICATION SITE REACTION 41
940 BEDRIDDEN 41
941 HAEMORRHAGIC ANAEMIA 41
942 HAEMORRHAGIC STROKE 41
943 HEPATITIS 41
944 IMPLANT SITE INFECTION 41
945 INTERNAL HAEMORRHAGE 41
946 INTERSTITIAL LUNG DISEASE 41
947 PELVIC PAIN 41
948 STRESS CARDIOMYOPATHY 41
949 ABSCESS 40
950 APPLICATION SITE DISCOLOURATION 40
951 APPLICATION SITE SWELLING 40
952 ESCHERICHIA URINARY TRACT INFECTION 40
953 EXOSTOSIS 40
954 EXTRASYSTOLES 40
955 FACIAL PAIN 40
956 GASTROINTESTINAL PAIN 40
957 INJECTION SITE INDURATION 40
958 MALIGNANT HYPERTENSION 40
959 PAROSMIA 40
960 PRODUCT DISPENSING ERROR 40
961 VASCULAR DEVICE INFECTION 40
962 WRIST FRACTURE 40
963 AMENORRHOEA 39
964 BASAL CELL CARCINOMA 39
965 CHOLESTASIS 39
966 CHOREOATHETOSIS 39
967 COLITIS ISCHAEMIC 39
968 DEVICE INFORMATION OUTPUT ISSUE 39
969 DRUG RESISTANCE 39
970 DRUG USE DISORDER 39
971 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 39
972 LIGAMENT SPRAIN 39
973 PARAESTHESIA ORAL 39
974 BLOOD PRESSURE DIASTOLIC INCREASED 38
975 ENTEROCOCCAL INFECTION 38
976 FAECALOMA 38
977 FAILURE TO THRIVE 38
978 HYPERTENSIVE HEART DISEASE 38
979 IMMUNE THROMBOCYTOPENIA 38
980 INCORRECT DOSE ADMINISTERED BY DEVICE 38
981 KIDNEY FIBROSIS 38
982 NEOPLASM PROGRESSION 38
983 NEUROLOGICAL DECOMPENSATION 38
984 PRE-EXISTING CONDITION IMPROVED 38
985 PRODUCT LEAKAGE 38
986 RESPIRATORY ACIDOSIS 38
987 UROSEPSIS 38
988 WRONG DRUG ADMINISTERED 38
989 AORTIC ANEURYSM 37
990 BLOOD PRESSURE DIASTOLIC ABNORMAL 37
991 CHOLECYSTECTOMY 37
992 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 37
993 DYSLIPIDAEMIA 37
994 EOSINOPHILIA 37
995 EUPHORIC MOOD 37
996 EYE INFECTION 37
997 GROIN PAIN 37
998 HYPERNATRAEMIA 37
999 MUSCLE DISORDER 37